Bringing New Pain Management Technologies To Market
Eva Medtec is the creator of Neuroglide, a system of automated therapy devices which provide effective, convenient, and sustainable pain management solutions.
Founded in 2012, the Eva team has worked tirelessly to develop proprietary technology, fine-tune manufacturing techniques, and demonstrate our product's therapeutic efficacy under clinical settings.
In 2021, Eva Medtec's flagship product, the Neuroglide Back/Neck Pad, was FDA-cleared for sale to consumers, validating what we already knew: that Neuroglide has enormous potential to improve the lives of those living with pain.
Eva Medtec is headquartered in Bloomington, MN, where devices are currently assembled in-house.
Better Health Through Innovation
Eva started with a clear mission: to develop unique, effective, and accessible therapeutic devices that lessened dependency on expensive and inconvenient therapies, drugs, and medical treatments. Our goal in creating Neuroglide is to bring affordable stress, recovery, and pain management to the mass market.
Prior to founding Eva Medtec, Ms. Waldridge founded Tactile Medical, where she held four patents as the inventor of the Flexitouch System for the treatment of lymphedema and venous insufficiency.
Ms. Waldridge served as Chairman of the Board and Vice President of Product Strategy from 1995 to 2007, and was also Chairman Emeritus and Chief Technologist from 2007 to 2010. Tactile Medical is currently valued at about $1B on revenues near $190M.